دورية أكاديمية
Microscopic spermatic cord denervation for chronic orchialgia/chronic scrotal content pain: operative outcomes and predictors of failure.
| العنوان: | Microscopic spermatic cord denervation for chronic orchialgia/chronic scrotal content pain: operative outcomes and predictors of failure. |
|---|---|
| المؤلفون: | Murthy PB; Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Parekh NV; Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Vij SC; Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Shoskes DA; Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. |
| المصدر: | Translational andrology and urology [Transl Androl Urol] 2020 Oct; Vol. 9 (5), pp. 1931-1936. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: AME Pub Country of Publication: China NLM ID: 101581119 Publication Model: Print Cited Medium: Print ISSN: 2223-4691 (Print) Linking ISSN: 22234683 NLM ISO Abbreviation: Transl Androl Urol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Hong Kong] : AME Pub., 2012- |
| مستخلص: | Background: To describe our institutional outcomes with microscopic spermatic cord denervation (MSCD) for chronic scrotal content paint (CSCP) and identify predictors of treatment failure. Methods: Retrospective chart review was performed to identify all MSCD performed by two surgeons at a single institution from 2010-2019. Patient demographic data and operative outcomes were collected. Patients were excluded from analysis if no post-operative follow up was available. Success was defined as complete resolution of bothersome pain. Multivariable logistic regression was utilized to identify predictors of treatment failure. Results: During the study period, 101 patients were identified in which 113 MSCD procedures were performed. Final analysis included 103 procedures across 93 patients. Mean age was 41.8 years (SD 13.2), mean BMI was 29.2 kg/m 2 (SD 5.96) and median months of pain preceding surgery were 24 (range, 3-300 months). Overall, 75/103 (73%) MSCD were successful. Of the failures, 5 patients had recurrence of pain greater than 6 months after surgery. Only the presence of pelvic floor muscle spasm (PFMS) independently predicted MSCD failure (OR 3.95, P=0.02). 9 of 19 (47%) patients with PFMS experienced treatment failure, while 19 of 84 (23%) without PFMS experienced failure. Conclusions: MSCD offers a therapeutic option for patients with refractory CSCP. The presence of PFMS is associated with lower surgical success rates. Patients with pre-operatively identified PFMS should be counseled regarding a higher risk of treatment failure. Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau-20-561). DAS serves as an unpaid editorial board member of Translational Andrology and Urology from Aug 2020 – Jul 2022; and he reports other from Triurol, personal fees from UroGen, outside the submitted work. The authors have no other conflicts of interest to declare. (2020 Translational Andrology and Urology. All rights reserved.) |
| References: | J Urol. 2015 Nov;194(5):1323-7. (PMID: 26004866) J Urol. 2010 Jan;183(1):177-81. (PMID: 19913802) Urology. 2010 Jun;75(6):1249-53. (PMID: 20363491) Transl Androl Urol. 2017 May;6(Suppl 1):S37-S43. (PMID: 28725616) Arch Phys Med Rehabil. 2008 Jan;89(1):16-23. (PMID: 18164325) J Urol. 2013 Feb;189(2):554-8. (PMID: 23260554) Curr Urol Rep. 2013 Oct;14(5):409-17. (PMID: 23943509) Eur Urol. 2013 May;63(5):953-9. (PMID: 23141933) Urology. 2018 Sep;119:39-43. (PMID: 29898380) J Urol. 2018 Apr;199(4):1015-1022. (PMID: 29079446) Eur Urol. 2002 Apr;41(4):392-7. (PMID: 12074809) Urology. 2019 Sep;131:144-149. (PMID: 31136771) J Urol. 2008 Sep;180(3):949-53. (PMID: 18639271) J Urol. 2013 Jul;190(1):265-70. (PMID: 23353047) J Neuroinflammation. 2011 Aug 30;8:109. (PMID: 21878125) Can J Urol. 2016 Dec;23(6):8546-8550. (PMID: 27995849) Asian J Androl. 2019 Jul-Aug;21(4):319-323. (PMID: 30416135) Ann Anat. 2011 Jul;193(4):267-75. (PMID: 21458249) J Urol. 2016 Jun;195(6):1841-7. (PMID: 26626219) BJU Int. 2018 Apr;121(4):667-673. (PMID: 29352521) J Sex Med. 2013 Mar;10(3):876-82. (PMID: 23016953) Trans Am Assoc Genitourin Surg. 1978;70:149-51. (PMID: 753015) |
| فهرسة مساهمة: | Keywords: Spermatic cord; denervation; orchialgia; pelvic floor |
| تواريخ الأحداث: | Date Created: 20201119 Latest Revision: 20220418 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC7658118 |
| DOI: | 10.21037/tau-20-561 |
| PMID: | 33209657 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2223-4691 |
|---|---|
| DOI: | 10.21037/tau-20-561 |